ATE477331T1 - Verfahren zum nachweis einer hiv-infektion - Google Patents
Verfahren zum nachweis einer hiv-infektionInfo
- Publication number
- ATE477331T1 ATE477331T1 AT07756200T AT07756200T ATE477331T1 AT E477331 T1 ATE477331 T1 AT E477331T1 AT 07756200 T AT07756200 T AT 07756200T AT 07756200 T AT07756200 T AT 07756200T AT E477331 T1 ATE477331 T1 AT E477331T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv infection
- detecting hiv
- infection
- hiv
- afd
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Marine Sciences & Fisheries (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79774506P | 2006-05-05 | 2006-05-05 | |
US89415007P | 2007-03-09 | 2007-03-09 | |
PCT/US2007/010750 WO2007130523A2 (en) | 2006-05-05 | 2007-05-04 | Compositions and methods for detecting and treating hiv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE477331T1 true ATE477331T1 (de) | 2010-08-15 |
Family
ID=38624429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07756200T ATE477331T1 (de) | 2006-05-05 | 2007-05-04 | Verfahren zum nachweis einer hiv-infektion |
Country Status (6)
Country | Link |
---|---|
US (2) | US7662547B2 (de) |
EP (2) | EP2021496B1 (de) |
AT (1) | ATE477331T1 (de) |
CA (1) | CA2651317A1 (de) |
DE (1) | DE602007008398D1 (de) |
WO (1) | WO2007130523A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2307367T3 (pl) | 2008-07-08 | 2015-03-31 | Univ Texas | Nowe inhibitory proliferacji i aktywacji białek przekazujących sygnał i aktywujących transkrypcję (STAT) |
US8450337B2 (en) | 2008-09-30 | 2013-05-28 | Moleculin, Llc | Methods of treating skin disorders with caffeic acid analogs |
EP3037421A3 (de) | 2008-11-25 | 2016-11-30 | University Of Rochester | Mlk-hemmer und verfahren zur verwendung |
US20130109687A1 (en) * | 2010-04-30 | 2013-05-02 | Gary J. Nabel | Methods of treating hiv infection: inhibition of dna dependent protein kinase |
US20150104442A1 (en) * | 2011-08-15 | 2015-04-16 | King's College London | Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence |
US10485800B2 (en) | 2012-11-30 | 2019-11-26 | The University Of Rochester | Mixed lineage kinase inhibitors for HIV/AIDS therapies |
TWI629720B (zh) * | 2015-09-30 | 2018-07-11 | 東京威力科創股份有限公司 | 用於濕蝕刻製程之溫度的動態控制之方法及設備 |
CN106074567A (zh) * | 2016-07-05 | 2016-11-09 | 湖北医药学院 | 葫芦素b在制备蛋白磷酸酶2a癌性抑制因子抑制剂中的应用 |
EP3570824A4 (de) * | 2017-01-17 | 2020-10-07 | Bar-Ilan University | Zusammensetzungen und verfahren zur kontrolle der aktivierung und funktion von natürlichen killerzellen |
WO2019147678A1 (en) * | 2018-01-23 | 2019-08-01 | Virongy L.L.C. | Cofilin phosphorylation for quantifying cd4 t cell damage and predict cd4 t cell recovery from anti-retroviral therapy |
CN110194793B (zh) * | 2018-02-26 | 2020-12-01 | 中国科学院武汉病毒研究所 | 一种抑制肌动蛋白重组的多肽及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932221A (en) * | 1997-10-30 | 1999-08-03 | Day; Charles E. | Genistin-enriched fraction from soy meal |
US7052676B2 (en) * | 2000-09-26 | 2006-05-30 | The Regents Of The University Of Michigan | Methods for inhibition of HIV replication using a small molecule inhibitor |
CN1100564C (zh) * | 2001-08-29 | 2003-02-05 | 周根发 | 用于治疗hiv感染的药物、其组合物及其用途 |
EP1633208A1 (de) * | 2003-05-27 | 2006-03-15 | DSM IP Assets B.V. | Neue diätetische zusammensetzungen und deren verwendung |
EP1542016A1 (de) * | 2003-12-11 | 2005-06-15 | Institut Gustave Roussy | PUMA, phosphoryliertes p53 und p38 MAPK als Marker für HIV-induzierte Apoptose in zirkulierenden T-Zellen eines infizierten Patienten |
WO2005103654A2 (fr) * | 2004-04-09 | 2005-11-03 | Bioalliance Pharma | Methode d’identification de composes actifs sur la replication du virus hiv. |
-
2007
- 2007-05-04 EP EP07756200A patent/EP2021496B1/de not_active Not-in-force
- 2007-05-04 US US11/744,776 patent/US7662547B2/en not_active Expired - Fee Related
- 2007-05-04 WO PCT/US2007/010750 patent/WO2007130523A2/en active Application Filing
- 2007-05-04 DE DE602007008398T patent/DE602007008398D1/de active Active
- 2007-05-04 CA CA002651317A patent/CA2651317A1/en not_active Abandoned
- 2007-05-04 AT AT07756200T patent/ATE477331T1/de not_active IP Right Cessation
- 2007-05-04 EP EP10006417A patent/EP2236620A3/de not_active Withdrawn
-
2009
- 2009-12-16 US US12/639,751 patent/US20100292181A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2651317A1 (en) | 2007-11-15 |
WO2007130523A3 (en) | 2008-06-19 |
EP2236620A2 (de) | 2010-10-06 |
EP2021496B1 (de) | 2010-08-11 |
DE602007008398D1 (de) | 2010-09-23 |
EP2236620A3 (de) | 2011-05-25 |
WO2007130523A2 (en) | 2007-11-15 |
EP2021496A2 (de) | 2009-02-11 |
US20080064026A1 (en) | 2008-03-13 |
US7662547B2 (en) | 2010-02-16 |
US20100292181A1 (en) | 2010-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE477331T1 (de) | Verfahren zum nachweis einer hiv-infektion | |
ATE531820T1 (de) | Gesundheitszustandstest | |
ATE499602T1 (de) | Signalprozessierungsschaltkreis mit ionensensitivem feldeffekttransistor sowie verfahren zur überwachung einer eigenschaft einer flüssigkeit | |
ATE523053T1 (de) | Verfahren zur erhöhung der positionsverfügbarkeit | |
DE602006004916D1 (de) | Verfahren zur Erfassung des Sturzes einer Person | |
ATE448524T1 (de) | Verfahren und systeme zur definition, identifikation und erfassung geometrischer eigenschaften | |
DE602005021684D1 (de) | Verfahren zur herstellung von pimecrolimus | |
ATE537098T1 (de) | System und verfahren zur erfassung der position einer aufzugskabine | |
DE602008003048D1 (de) | Verfahren und Vorrichtung zur Vermessung einer Objektoberfläche mittels eines Abstandssensors, der den Brennpunkt misst | |
DK2310043T3 (da) | Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere | |
DE502005008461D1 (de) | Verfahren und laseranordnung mit einer vorrichtung zur zustandserkennung eines optischen elements | |
ATE446572T1 (de) | Verfahren und system zur bereitstellung eines tonsignals mit erweiterter bandbreite | |
DE602005013633D1 (de) | Vorrichtung zur Detektion von atmosphärischer Turbulenz | |
ATE373858T1 (de) | Verfahren und vorrichtung zur verringerung von geräuschbeeinträchtigung eines alternativen sensorsignals während multisensorischer sprachverstärkung | |
DE602005027919D1 (de) | Vorrichtung zur Verhinderung einer lateralen Verschiebung für Stabilisatoren | |
DE602006009625D1 (de) | Vorrichtung zur Messung von Dimensionen und vertikale Säule mit einer solchen Vorrichtung | |
DE602006017483D1 (de) | Vorrichtung zur Ölstandsmessung | |
DE602005018474D1 (de) | Nachweis von hiv-typen und hiv-subtypen | |
DE502004005365D1 (de) | Verfahren zur quantitativen Messung von Ablagerung auf festen Oberflächen | |
DE502008002117D1 (de) | Sensoranordnung zur Erfassung von Objekten | |
ATE551605T1 (de) | Verfahren und vorrichtungen zur erkennung von biofilmen | |
WO2016141370A3 (en) | Methods and compositions for identifying pathogenic vibrio parahaemolyticus | |
MX2017011512A (es) | Metodos de visualizacion de la sensibilidad antimicrobiana de cepas aisladas biologicas. | |
ATE528650T1 (de) | Verfahren zum nachweis und zur diagnose einer infektion mit trypanosoma cruzi | |
DE50108910D1 (de) | Vorrichtung zur erfassung der pmd von optoelektronischen übertragungsstrecken |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |